Exelixis Inc. buy Royal Bank of Canada
Start price
13.12.23
/
50%
€21.38
Target price
13.12.24
€24.09
Performance (%)
57.81%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. The BUY prediction by Royal_Bank_of_Canada for Exelixis Inc. saw massive gains of 57.81%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -0.368% | -0.368% | 25.373% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $26.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten